Califf Nomination Swimming Upstream With Multiple Holds Now Possible
This article was originally published in The Pink Sheet Daily
Executive Summary
Two Senators could place holds on Robert Califf's nomination for FDA commissioner as HELP Committee sends it to the floor.
You may also be interested in...
Gottlieb Advances, But FDA's Future Seems Increasingly Partisan
Senate committee votes to send the FDA Commissioner nominee to the Senate floor, but with only two Democratic votes.
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise, but is there an appetite for another reorganization?